Financial Counselors Inc. Sells 807 Shares of Veralto Co. (NYSE:VLTO)

Financial Counselors Inc. reduced its position in shares of Veralto Co. (NYSE:VLTO) by 23.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,698 shares of the company’s stock after selling 807 shares during the quarter. Financial Counselors Inc.’s holdings in Veralto were worth $258,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC raised its holdings in shares of Veralto by 3.2% in the first quarter. Global Retirement Partners LLC now owns 3,966 shares of the company’s stock valued at $352,000 after acquiring an additional 123 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Veralto by 2.7% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,406 shares of the company’s stock worth $516,000 after purchasing an additional 142 shares during the period. Perkins Coie Trust Co boosted its stake in shares of Veralto by 2.2% during the second quarter. Perkins Coie Trust Co now owns 7,128 shares of the company’s stock valued at $680,000 after purchasing an additional 151 shares in the last quarter. Graypoint LLC increased its holdings in Veralto by 3.8% during the second quarter. Graypoint LLC now owns 4,407 shares of the company’s stock valued at $421,000 after buying an additional 160 shares during the period. Finally, Valeo Financial Advisors LLC raised its stake in Veralto by 5.0% in the second quarter. Valeo Financial Advisors LLC now owns 3,533 shares of the company’s stock worth $337,000 after buying an additional 168 shares in the last quarter. 91.28% of the stock is owned by institutional investors.

Veralto Trading Up 0.5 %

NYSE VLTO opened at $110.85 on Thursday. The stock has a market cap of $27.36 billion and a P/E ratio of 33.78. The company has a current ratio of 1.96, a quick ratio of 1.70 and a debt-to-equity ratio of 1.56. Veralto Co. has a 12-month low of $65.51 and a 12-month high of $112.77. The company has a fifty day simple moving average of $103.72 and a two-hundred day simple moving average of $96.91.

Veralto (NYSE:VLTO) last issued its quarterly earnings results on Thursday, July 25th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.28 billion. Veralto had a return on equity of 58.82% and a net margin of 15.60%. The firm’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.80 EPS. On average, analysts forecast that Veralto Co. will post 3.45 earnings per share for the current year.

Insider Activity at Veralto

In other Veralto news, SVP Mattias Bystrom sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $105.89, for a total transaction of $317,670.00. Following the completion of the transaction, the senior vice president now directly owns 31,045 shares of the company’s stock, valued at approximately $3,287,355.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Veralto news, SVP Mattias Bystrom sold 3,000 shares of Veralto stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $105.89, for a total transaction of $317,670.00. Following the completion of the transaction, the senior vice president now owns 31,045 shares in the company, valued at approximately $3,287,355.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jennifer Honeycutt sold 13,191 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $111.98, for a total value of $1,477,128.18. Following the completion of the sale, the chief executive officer now owns 138,546 shares in the company, valued at approximately $15,514,381.08. The disclosure for this sale can be found here. Insiders have sold a total of 25,096 shares of company stock worth $2,772,707 over the last quarter. Insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. The Goldman Sachs Group increased their target price on Veralto from $104.00 to $116.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Stifel Nicolaus raised their price objective on Veralto from $110.00 to $117.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Veralto from $100.00 to $109.00 and gave the stock a “hold” rating in a report on Monday, July 29th. TD Cowen raised their price target on shares of Veralto from $95.00 to $100.00 and gave the company a “hold” rating in a report on Tuesday, July 30th. Finally, UBS Group started coverage on shares of Veralto in a research note on Tuesday, August 13th. They set a “neutral” rating and a $118.00 price objective for the company. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $104.46.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.